Publication Name	World Journal of Gastroenterology
Manuscript ID	7581
Country	China

Received	2013-11-25 15:52
Peer-Review Started	2013-11-25 20:26
To Make the First Decision	2013-12-16 18:04
Return for Revision	2013-12-17 14:17
Revised
Second Decision	2014-03-05 14:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-05 15:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-17 20:14
Typeset the Manuscript	2014-04-22 08:52
Publish the Manuscript Online	2014-05-07 10:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Clinical Trials Study
Article Title	Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer
Manuscript Source	Invited Manuscript
All Author List	Jing-Ping Yu, Su-Ping Sun, Zhi-Qiang Sun, Xin-Chu Ni, Jian Wang, Yi Li, Li-Jun Hu and Dong-Qing Li
Funding Agency and Grant Number	Funding Agency Grant Number Scientific Research Project of the Health Department of Jiangsu Province, China Z201220 Major Project of the Health Department of Changzhou, China ZD201105 Changzhou Sci-Tech Support Project for Social Development CE20125021
Corresponding Author	Su-Ping Sun, PhD, Department of Radiation Oncology, Changzhou Second People’s Hospital, Affiliated to Nanjing Medical University, Labor Lane, Changzhou 213003, Jiangsu Province, China. ssp56@126.com
Key Words	Thalidomide; Radiotherapy; Esophageal cancer; Vascular endothelial growth factor
Core Tip	Vascular endothelial growth factor (VEGF)-based individualized radiotherapy for esophageal cancer (EC) was achieved in this clinical study. EC patients undergoing radiation treatment may receive different protocols: thalidomide combined with radiation or radiation alone, according to their VEGF level. This study was designed to set appropriate radiotherapy regimens for different patients, improve sensitivity, and decrease resistance in radiation oncology.
Publish Date	2014-05-07 10:10
Citation	Yu JP, Sun SP, Sun ZQ, Ni XC, Wang J, Li Y, Hu LJ, Li DQ. Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer. World J Gastroenterol 2014; 20(17): 5098-5103
URL	http://www.wjgnet.com/1007-9327/full/v20/i17/5098.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i17.5098

Full Article (PDF)	WJG-20-5098.pdf
Full Article (Word)	WJG-20-5098.doc
Manuscript File	7581-Review.doc
Answering Reviewers	7581-Answering reviewers.pdf
Copyright License Agreement	7581-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	7581-Language certificate.PDF
Peer-review Report	7581-Peer review(s).pdf
Scientific Editor Work List	7581-Scientific editor work list.doc